Evidence map›Paper›PMID 37380519›Full record

ArticleJournal of geriatric oncology2023

A pilot study of adherence to lenalidomide among older patients with multiple myeloma.

Alice E Silberstein, Mark A Fiala, Kah Poh Loh, Theresa Cordner, Hira Mian, Tanya M Wildes

Abstract read
In one paragraph

Article in Journal of geriatric oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Psychometric evaluation of the PROMISJournal of patient-reported outcomes · 2026
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alice E SilbersteinWashington University School of Medicine, St. Louis, MO, USA.
Mark A FialaWashington University School of Medicine, St. Louis, MO, USA; College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, USA.
Kah Poh LohDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Theresa CordnerWashington University School of Medicine, St. Louis, MO, USA.
Hira MianMcMaster University, Hamilton, ON, Canada.
Tanya M WildesDivision of Hematology/Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE, USA. Electronic address: twildes@unmc.edu.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials NetworkU10CA180863 · NCI · QUEEN'S UNIVERSITY AT KINGSTON · PI Janet Ellen Dancey · 2014 to 2026
$40.4M
NCI NIH HHS P30 CA091842NCI NIH HHS U10 CA180863NCI NIH HHS UG1 CA189823
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsDexamethasoneHumansLenalidomidePilot ProjectsDexamethasoneLenalidomide

Identifiers

PMID37380519
PMCPMC10529650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.